Evolution of Pulmonary Capillary Blood Volume
- Conditions
- Pulmonary Embolism
- Interventions
- Other: diffusion NO/CO method
- Registration Number
- NCT00941187
- Brief Summary
The purpose of this monocentric, preliminary study is to assess the evolution of pulmonary capillary blood volume (Vc), measured by the double diffusion nitric oxide/carbon monoxide (NO/CO) method (Guenard et al.; Respir Physiol 1987), from the starting of the anticoagulant therapy to 6 months after, and to search correlations with the evolution of clinical (dyspnea and results of the 6 minutes walking test), biological (BNP; Troponin), echocardiographic (right ventricular dysfunction, pulmonary arterial pressure) and ventilation/perfusion lung scan data.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 50
- Patient with a first episode of symptomatic pulmonary embolism, treated with anticoagulant
- Age from 18 to 75 years-old
- Confirmed pulmonary embolism in the past
- Massive pulmonary embolism, thrombolytic treatment
- Confirmed left heart systolic dysfunction
- Confirmed asthma, chronic obstructive pulmonary disease or pulmonary fibrosis
- Expected life below 6 months
- Pleural effusion with indication of evacuation
- Bronchopulmonary cancer
- Pulmonary surgery with resection of two lobes minimum
- Predictable incapacity to complete the 6 minutes walking test
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description patients after a first episode of pulmonary embolism diffusion NO/CO method -
- Primary Outcome Measures
Name Time Method difference of pulmonary capillary blood volume (Vc) from J0 to 6 months from the starting of the anticoagulant therapy to 6 months after
- Secondary Outcome Measures
Name Time Method correlations with the evolution of clinical (dyspnea and results of the 6 minutes walking test), biological (BNP; Troponin), echocardiographic (right ventricular dysfunction, pulmonary arterial pressure) and ventilation/perfusion lung scan data from the starting of the anticoagulant therapy to 6 months after
Trial Locations
- Locations (2)
Departement of pneumology, CHU Saint-Etienne
🇫🇷Saint-Etienne, France
Department of Medicine and Therapeutic, CHU Saint-Etienne
🇫🇷Saint-etienne, France